Clinical trials
Active, not recruiting Kidney Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| AstraZeneca | 1 |
| Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 1 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| John Sievenpiper | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
| Western University, Canada | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Diseases | 9 |
| Renal Insufficiency, Chronic | 4 |
| Urologic Diseases | 3 |
| Cardiovascular Diseases | 2 |
| Glomerulonephritis | 2 |
| Glomerulonephritis, IGA | 2 |
| Kidney Failure, Chronic | 2 |
| Atherosclerosis | 1 |
| Cerebrovascular Disorders | 1 |
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.